2024
Cannabis Use and Cannabis Use Disorder Among U.S. Adults with Psychiatric Disorders: 2001-2002 and 2012-2013
Hasin D, Mannes Z, Livne O, Fink D, Martins S, Stohl M, Olfson M, Cerdá M, Keyes K, Keyhani S, Wisell C, Bujno J, Saxon A. Cannabis Use and Cannabis Use Disorder Among U.S. Adults with Psychiatric Disorders: 2001-2002 and 2012-2013. Substance Use & Misuse 2024, 60: 285-292. PMID: 39533528, PMCID: PMC11710973, DOI: 10.1080/10826084.2024.2423374.Peer-Reviewed Original ResearchConceptsCannabis use disorderPsychiatric disordersCannabis useNon-medical cannabis useCannabis outcomesUse disorderDSM-IV cannabis use disorderRates of cannabis use disordersRates of cannabis useCannabis use disorder prevalenceAntisocial personality disorderU.S. adultsPersonality disorderDSM-IVVeterans AdministrationPatient samplesNon-medical useDisordersPrevalence differencesU.S. general populationNationally Representative SampleCannabisVA patientsAdultsDisproportionate increase
2023
Examining sociodemographic correlates of opioid use, misuse, and use disorders in the All of Us Research Program.
Yeh H, Peltz-Rauchman C, Johnson C, Pawloski P, Chesla D, Waring S, Stevens A, Epstein M, Joseph C, Miller-Matero L, Gui H, Tang A, Boerwinkle E, Cicek M, Clark C, Cohn E, Gebo K, Loperena R, Mayo K, Mockrin S, Ohno-Machado L, Schully S, Ramirez A, Qian J, Ahmedani B. Examining sociodemographic correlates of opioid use, misuse, and use disorders in the All of Us Research Program. PLOS ONE 2023, 18: e0290416. PMID: 37594966, PMCID: PMC10437856, DOI: 10.1371/journal.pone.0290416.Peer-Reviewed Original ResearchConceptsOpioid use disorderOpioid usePrescription opioidsElectronic health recordsReduced oddsDiagnosis of OUDSociodemographic characteristicsPrevalence of OUDNonmedical useLifetime opioid useEHR dataNon-Hispanic white participantsImportant clinical informationNon-medical useLifetime prevalenceStreet opioidsHigher oddsOpioidsClinical informationUse disordersUs Research ProgramSociodemographic correlatesLogistic regressionPrevalenceHealth records
2021
Defining “Doctor Shopping” with Dispensing Data: A Scoping Review
Delcher C, Bae J, Wang Y, Doung M, Fink D, Young H. Defining “Doctor Shopping” with Dispensing Data: A Scoping Review. Pain Medicine 2021, 23: 1323-1332. PMID: 34931686, DOI: 10.1093/pm/pnab344.Peer-Reviewed Original Research
2020
Co-occurring opioid and sedative use disorder: Gender differences in use patterns and psychiatric co-morbidities in the United States
Ellis JD, Pittman BP, McKee SA. Co-occurring opioid and sedative use disorder: Gender differences in use patterns and psychiatric co-morbidities in the United States. Journal Of Substance Use And Addiction Treatment 2020, 114: 108012. PMID: 32527509, PMCID: PMC7292885, DOI: 10.1016/j.jsat.2020.108012.Peer-Reviewed Original ResearchConceptsSedative use disorderOpioid use disorderUse disordersCo-occurring opioid use disorderMeeting criteriaPsychiatric conditionsCurrent opioid use disorderCo-occurring opioidPersonality disorderRisk of overdoseLogistic regression analysisCo-occurring symptomsImplementation of treatmentPosttraumatic stress disorderSchizotypal personality disorderAntisocial personality disorderNon-medical useBaseline characteristicsDepressive disorderGender-stratified logistic regression analysesPrescription monitoringOwn prescriptionsOpioidsStress disorderNESARC-III
2017
Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial
Molfenter T, Knudsen HK, Brown R, Jacobson N, Horst J, Van Etten M, Kim JS, Haram E, Collier E, Starr S, Toy A, Madden L. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial. Implementation Science 2017, 12: 135. PMID: 29141653, PMCID: PMC5688699, DOI: 10.1186/s13012-017-0665-x.Peer-Reviewed Original ResearchConceptsOpioid use disorderAddiction treatment fieldPrevalence of OUDSubstantial public health significanceOpioid misuse epidemicExtended-release naltrexonePrimary treatment outcomeEvidence-based pharmacotherapyAddiction treatment workforceSignificant health issuePublic health significanceAddiction treatment providersNaltrexone patientsNon-medical useOUD pharmacotherapyTreatment fieldOUD patientsBuprenorphine patientsPrescription opioidsCluster RCTIntervention periodTreatment outcomesImplementation interventionsOverdose deathsUse disordersReply to Osborne & Serdarevic (2017): Potential impact of exposure definition when examining non‐medical use of prescription opioids among US veterans
Banerjee G, Edelman EJ, Barry DT, Becker WC, Cerdá M, Crystal S, Gaither JR, Gordon AJ, Gordon KS, Kerns RD, Martins SS, Fiellin DA, Marshall BDL. Reply to Osborne & Serdarevic (2017): Potential impact of exposure definition when examining non‐medical use of prescription opioids among US veterans. Addiction 2017, 112: 1510-1511. PMID: 28608455, DOI: 10.1111/add.13864.Peer-Reviewed Case Reports and Technical NotesReply to Ruan et al. (2017): Non‐medical use of prescription opioids is associated with heroin initiation among US veterans
Banerjee G, Edelman EJ, Barry DT, Becker WC, Cerdá M, Crystal S, Gaither JR, Gordon AJ, Gordon KS, Kerns RD, Martins SS, Fiellin DA, Marshall BD. Reply to Ruan et al. (2017): Non‐medical use of prescription opioids is associated with heroin initiation among US veterans. Addiction 2017, 112: 728-729. PMID: 28120531, DOI: 10.1111/add.13710.Peer-Reviewed Case Reports and Technical Notes
2016
Non‐medical use of prescription opioids is associated with heroin initiation among US veterans: a prospective cohort study
Banerjee G, Edelman EJ, Barry DT, Becker WC, Cerdá M, Crystal S, Gaither JR, Gordon AJ, Gordon KS, Kerns RD, Martins SS, Fiellin DA, Marshall BD. Non‐medical use of prescription opioids is associated with heroin initiation among US veterans: a prospective cohort study. Addiction 2016, 111: 2021-2031. PMID: 27552496, PMCID: PMC5056813, DOI: 10.1111/add.13491.Peer-Reviewed Original ResearchConceptsMultivariable Cox regression modelsNon-medical useCox regression modelHeroin initiationPrescription opioidsHeroin useCohort studyUS veteransOpioid use disorder diagnosisVeterans Aging Cohort StudyProspective cohort studyAging Cohort StudyIllicit opioid usePrimary care clinicsPrimary outcome measureStrong risk factorPost-traumatic stress disorderUninfected veteransUninfected patientsOpioid useRegression modelsCare clinicsPain interferencePrior diagnosisPrimary exposure
2015
Incident non-medical use of prescription opioids is associated with heroin initiation among U.S. veterans: A prospective cohort study
Banerjee G, Edelman E, Barry D, Becker W, Cerda M, Crystal S, Gaither J, Gordon A, Gordon K, Kerns R, Martins S, Fiellin D, Marshall B. Incident non-medical use of prescription opioids is associated with heroin initiation among U.S. veterans: A prospective cohort study. Drug And Alcohol Dependence 2015, 156: e14-e15. DOI: 10.1016/j.drugalcdep.2015.07.958.Peer-Reviewed Original ResearchNon-Medical Prescription Opioid Use and Prescription Opioid Use Disorder: A Review.
Tetrault JM, Butner JL. Non-Medical Prescription Opioid Use and Prescription Opioid Use Disorder: A Review. The Yale Journal Of Biology And Medicine 2015, 88: 227-33. PMID: 26339205, PMCID: PMC4553642.Peer-Reviewed Original ResearchConceptsPrescription opioid use disorderOpioid use disorderNon-medical useUse disordersPrescription opioidsMedical prescription opioid usePrescription opioid useOpioid useTreatment optionsHeroin useEpidemic proportionsPotential progressionDrug useRelated stigmaMedical communityDisordersDevastating consequencesOpioidsUnited StatesReview articleUnanswered questionsNational effortsEpidemiologyProgression
2010
Sedative-Hypnotics and Anxiolytics
Arnaout B, Petrakis I. Sedative-Hypnotics and Anxiolytics. 2010, 511-523. DOI: 10.1007/978-1-4419-0338-9_23.Peer-Reviewed Original ResearchCentral nervous system depressantsPsychiatric adverse eventsGroup of medicationsNon-benzodiazepine hypnoticsNon-medical useAdverse eventsSexual dysfunctionSleep disordersSedative hypnoticsPsychotic manifestationsCognitive disordersTherapeutic valueGeneral medicineAnxiety disordersMedicationsDisordersAnxiolyticsDeleterious effectsAbuseHypnoticsDysfunctionBenzodiazepinesEpidemiologyIntoxicationNeurology
2007
Non-medical use, abuse and dependence on prescription opioids among U.S. adults: Psychiatric, medical and substance use correlates
Becker WC, Sullivan LE, Tetrault JM, Desai RA, Fiellin DA. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: Psychiatric, medical and substance use correlates. Drug And Alcohol Dependence 2007, 94: 38-47. PMID: 18063321, DOI: 10.1016/j.drugalcdep.2007.09.018.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgoraphobiaAlcohol DrinkingChildChronic DiseaseCross-Sectional StudiesDiagnostic and Statistical Manual of Mental DisordersDrug PrescriptionsFactor Analysis, StatisticalFemaleHealth StatusHumansMaleOpioid-Related DisordersPainPanic DisorderPhobic DisordersPrevalenceSurveys and QuestionnairesUnited StatesConceptsAbuse/dependenceNon-medical usePast-year non-medical usePrescription opioidsLower self-rated health statusNon-medical prescription opioid useAgoraphobic symptomsSelf-rated health statusPrescription opioid useSubstance use correlatesCross-sectional surveyRespondents 18 yearsOpioid useMultivariable analysisPrescription medicationsMultivariable associationsOpioidsHealth statusSubstance misuseDrug useMeet criteriaU.S. adultsPoor healthSubstance useUse correlatesGender and non‐medical use of prescription opioids: results from a national US survey*
Tetrault JM, Desai RA, Becker WC, Fiellin DA, Concato J, Sullivan LE. Gender and non‐medical use of prescription opioids: results from a national US survey*. Addiction 2007, 103: 258-268. PMID: 18042194, DOI: 10.1111/j.1360-0443.2007.02056.x.Peer-Reviewed Original ResearchConceptsPast-year non-medical useNon-medical usePrescription opioidsDrug useSedative/tranquilizer useIllicit drug use disordersAlcohol abuse/dependenceDrug use disordersSerious mental illnessAbuse/dependenceIllicit drug useIllicit substance useSelf-reported alcoholGender-specific factorsCigarette smokingPrescription medicationsRisk factorsOpioidsUse disordersTranquilizer useGender-related factorsMental illnessUS residenceGreater riskSubstance useIllicit Use of Opioids: Is OxyContin® a “Gateway Drug”?
Grau LE, Dasgupta N, Harvey A, Irwin K, Givens A, Kinzly M, Heimer R. Illicit Use of Opioids: Is OxyContin® a “Gateway Drug”? American Journal On Addictions 2007, 16: 166-173. PMID: 17612819, DOI: 10.1080/10550490701375293.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply